valine has been researched along with sirolimus in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 13 (61.90) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
Anthony, JC; Anthony, TG; Jefferson, LS; Kimball, SR; Vary, TC; Yoshizawa, F | 1 |
Eto, Y; Ijichi, C; Matsumura, T; Tsuji, T | 1 |
Cota, D; Kozma, SC; Proulx, K; Seeley, RJ; Smith, KA; Thomas, G; Woods, SC | 1 |
Bose, AK; Carr, RD; Mocanu, MM; Yellon, DM | 1 |
Choi, JI; Hong, SJ; Joo, HJ; Lim, DS; Lim, SY; Park, SM; Shim, WJ; Shin, SY | 1 |
Chen, JS; Cheng, DR; Cheng, Z; Ji, SM; Li, LS; Liu, ZH; Sha, GZ; Wen, JQ | 1 |
Behnisch, B; Heilmann, T; Peters, S; Richter, C | 1 |
Kingsbury, JM; McCusker, JH | 1 |
Bernardi, G; Caioli, S; Canu, N; Carunchio, I; Curcio, L; Molinari, M; Pica, F; Pieri, M; Viscomi, MT; Zona, C | 1 |
Frey, JU; Navakkode, S; Sacktor, TC; Sajikumar, S | 1 |
Ahn, CM; Choi, SC; Hong, SJ; Kim, JS; Lim, DS; Park, JH | 1 |
Barbara, del B; Casolaro, M; Del Bello, B; Emilia, M; Maellaro, E | 1 |
Chang, SC; Delpire, E; Ghosh, A; Hall, BJ; Held, RG; Wang, CC; Yang, L | 1 |
Collins, JJ; Ferree, A; Guillily, M; Li, H; Smith, K; Squillace, R; Takashima, A; Weigele, M; Wolozin, B | 1 |
Boivin, G; Canivet, C; Menasria, R; Piret, J; Rhéaume, C | 1 |
Ashkenazi, S; Berent, E; Weizman, A; Yuhas, Y | 1 |
Frey, A; Gerken, G; Herzer, K; Piras-Straub, K; Timm, J; Walker, A | 1 |
Dong, X; Helmbrecht, A; Loor, JJ; Saremi, B; Wang, Z; Zhou, Z | 1 |
Dong, X; Helmbrecht, A; Loor, JJ; Saremi, B; Wang, L; Wang, Z; Zhou, Z | 1 |
Dolman, GE; Gelson, WT; Selby, P | 1 |
3 trial(s) available for valine and sirolimus
Article | Year |
---|---|
Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biomarkers; Cholesterol; Cholesterol, LDL; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hypertension; Immunosuppressive Agents; Interleukin-6; Male; Middle Aged; Single-Blind Method; Sirolimus; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2007 |
Therapeutic effect of Tripterygium wilfordii on proteinuria associated with sirolimus in renal transplant recipients.
Topics: Adult; Antihypertensive Agents; China; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Plant Extracts; Proteinuria; Sirolimus; Tetrazoles; Tripterygium; Valine; Valsartan; Young Adult | 2008 |
Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
Topics: Adiponectin; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Coronary Stenosis; Diabetes Mellitus, Type 2; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hypertension; Interleukin-6; Male; Middle Aged; Neointima; Prospective Studies; Single-Blind Method; Sirolimus; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography, Interventional; Valine; Valsartan | 2011 |
18 other study(ies) available for valine and sirolimus
Article | Year |
---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway.
Topics: Animals; Carrier Proteins; Electrophoresis, Polyacrylamide Gel; Eukaryotic Initiation Factor-4E; Food; Food Deprivation; Intracellular Signaling Peptides and Proteins; Isoleucine; Leucine; Male; Muscle Proteins; Muscle, Skeletal; Peptide Initiation Factors; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Sirolimus; Valine | 2000 |
Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system.
Topics: Albumins; Amino Acids, Branched-Chain; Animals; Carrier Proteins; Cells, Cultured; Dose-Response Relationship, Drug; Hepatocytes; Immunoblotting; Intracellular Signaling Peptides and Proteins; Isoleucine; Leucine; Male; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Binding; Protein Kinases; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Valine | 2003 |
Hypothalamic mTOR signaling regulates food intake.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Eating; Energy Intake; Energy Metabolism; Fasting; Hypothalamus; Injections, Intraventricular; Leptin; Leucine; Neurons; Neuropeptide Y; Phosphorylation; Protein Kinases; Rats; Rats, Long-Evans; Ribosomal Protein S6; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Valine; Weight Loss | 2006 |
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway.
Topics: Animals; Blotting, Western; Disease Models, Animal; Enzyme Inhibitors; Glucagon-Like Peptide 1; In Vitro Techniques; Incretins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Protein Kinases; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Valine | 2007 |
First-in-man use of polymer-free valsartan-eluting stents in small coronary vessels: a comparison to polymer-free rapamycin (2%)-eluting stents.
Topics: Aged; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Sirolimus; Tetrazoles; Valine; Valsartan | 2009 |
Cytocidal amino acid starvation of Saccharomyces cerevisiae and Candida albicans acetolactate synthase (ilv2{Delta}) mutants is influenced by the carbon source and rapamycin.
Topics: Acetolactate Synthase; Animals; Antifungal Agents; Candida albicans; Carbon; Fungal Proteins; Isoleucine; Male; Mice; Microbial Viability; Mutation; Phenotype; Saccharomyces cerevisiae; Sirolimus; Valine; Virulence | 2010 |
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture.
Topics: Action Potentials; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Electrophysiology; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Neurons; Phosphorylation; Protein Serine-Threonine Kinases; Sirolimus; Sodium Channels; Superoxide Dismutase; Superoxide Dismutase-1; TOR Serine-Threonine Kinases; Valine | 2010 |
Protein kinase Mzeta is essential for the induction and maintenance of dopamine-induced long-term potentiation in apical CA1 dendrites.
Topics: Animals; Benzazepines; Biophysics; CA1 Region, Hippocampal; Dactinomycin; Dendrites; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Immunosuppressive Agents; In Vitro Techniques; Long-Term Potentiation; Male; Neurons; Patch-Clamp Techniques; Peptides; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Sirolimus; Time Factors; Valine | 2010 |
Hydrogel containing L-valine residues as a platform for cisplatin chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Sirolimus; Temperature; Valine | 2011 |
A critical role for GluN2B-containing NMDA receptors in cortical development and function.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cerebral Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Immunosuppressive Agents; Mice; Mice, Knockout; Patch-Clamp Techniques; Piperidines; Receptors, N-Methyl-D-Aspartate; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Small Interfering; Sirolimus; Social Behavior; Sodium Channel Blockers; Tetrodotoxin; Time Factors; Valine | 2011 |
Regulation of physiologic actions of LRRK2: focus on autophagy.
Topics: Animals; Animals, Genetically Modified; Autophagy; Caenorhabditis elegans; Disease Models, Animal; Gene Expression Regulation; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Methionine; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Sirolimus; tau Proteins; Valine | 2012 |
Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Artemisinins; Artesunate; Brain; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Female; Immunologic Factors; Injections, Intraperitoneal; Mice, Inbred BALB C; Sirolimus; Survival Analysis; Treatment Outcome; Valacyclovir; Valine; Viral Load | 2015 |
Ketamine upregulates eNOS expression in human astroglial A172 cells: Possible role in its antidepressive properties.
Topics: Astrocytes; Cell Line, Transformed; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glioblastoma; Humans; Immunosuppressive Agents; Ketamine; MAP Kinase Signaling System; N-Methylaspartate; Nitric Oxide Synthase Type III; RNA, Messenger; Sirolimus; Time Factors; Up-Regulation; Valine | 2017 |
The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype.
Topics: Antiviral Agents; Benzimidazoles; Calcineurin Inhibitors; Carbamates; Cell Line; Cyclosporine; Everolimus; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Pyrrolidines; Sirolimus; Sofosbuvir; Valine; Virus Replication | 2018 |
Varying the ratio of Lys:Met while maintaining the ratios of Thr:Phe, Lys:Thr, Lys:His, and Lys:Val alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription.
Topics: Amino Acid Sequence; Amino Acid Transport Systems; Amino Acids; Animals; Caseins; Cattle; Epithelial Cells; Female; Histidine; Lactation; Lysine; Mammary Glands, Animal; Milk; Milk Proteins; Phenylalanine; Phosphorylation; Protein Biosynthesis; Signal Transduction; Sirolimus; Threonine; TOR Serine-Threonine Kinases; Transcription, Genetic; Valine | 2018 |
Increasing the availability of threonine, isoleucine, valine, and leucine relative to lysine while maintaining an ideal ratio of lysine:methionine alters mammary cellular metabolites, mammalian target of rapamycin signaling, and gene transcription.
Topics: Amino Acid Sequence; Animals; Cattle; Female; Isoleucine; Leucine; Lysine; Mammary Glands, Animal; Methionine; Peptide Fragments; Sirolimus; Threonine; Transcription, Genetic; Valine | 2018 |
Ombitasvir/paritaprevir/ritonavir plus dasabuvir regimen may be used safely in combination with sirolimus for the treatment of chronic hepatitis C.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; End Stage Liver Disease; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Proline; Ritonavir; Sirolimus; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |